ReiThera is manufacturing the drug substance for Sabin Vaccine Institute’s ChAd3 Ebola Sudan vaccine and performing fill/finish for the first 9,600 doses. Contract development manufacturing organization (CDMO) ReiThera will produce Sabin’s ChAd3 (chimpanzee adenovirus) Ebola Sudan single-dose vaccine at its Castel Romano Technopole plant, Italy, which it opened in November. ReiThera claims Sabin is the first organization to provide the World Health Organization (WHO) its Ebola Sudan vaccine to support the Ebola Sudan outbreak in Uganda.  Around 1,100 doses of Sabin’s vaccine…

As the year draws to a close, BioProcess Insider brings you our Christmas quiz special where we test your 2022 M&A knowledge. 2022 has been a year full of M&A activity, some with big price tags and others that have seen companies move into different modalities and service offerings. BioProcess Insider wanted to bring our readers some festive fun ahead of Christmas and the New Year. Happy Christmas from Bioprocess Insider and here’s to another year full M&A activity!   Loading…